Kruse Bo (CIK 0001752940)

Latest company ownership

Shares held
31,371
Last filed at
May 31, 2024
Confidence Score
50.0
2025Q4
Confidence Score History
2020Q2 2025Q4

Recent buy/sell transactions

Exec date Filing date Company Role Signal Confidence Shares % of shares Under plan? Amount (USD)
May 30, 2024 May 31, 2024 Y-mAbs Therapeutics, Inc. CFO Sell 20.0 -60,000 -12.45% ✗ $723.1K
Feb 22, 2022 Feb 23, 2022 Y-mAbs Therapeutics, Inc. CFO Sell 45.0 -4,000 -2.16% ✓ $31.4K
Feb 4, 2022 Feb 7, 2022 Y-mAbs Therapeutics, Inc. CFO Sell 45.0 -4,000 -2.12% ✓ $31.9K
Jan 24, 2022 Jan 25, 2022 Y-mAbs Therapeutics, Inc. CFO Sell 45.0 -4,000 -2.07% ✓ $39.4K
Jan 4, 2022 Jan 5, 2022 Y-mAbs Therapeutics, Inc. CFO Sell 41.3 -4,000 -2.03% ✓ $68.5K
Dec 22, 2021 Dec 23, 2021 Y-mAbs Therapeutics, Inc. CFO Sell 45.0 -4,000 -1.99% ✓ $65.4K
Dec 6, 2021 Dec 7, 2021 Y-mAbs Therapeutics, Inc. CFO Sell 45.0 -4,000 -1.95% ✓ $65.4K
Nov 22, 2021 Nov 23, 2021 Y-mAbs Therapeutics, Inc. CFO Sell 45.0 -4,000 -1.91% ✓ $72.4K
Nov 4, 2021 Nov 5, 2021 Y-mAbs Therapeutics, Inc. CFO Sell 45.0 -4,000 -1.88% ✓ $110.2K
Oct 22, 2021 Oct 26, 2021 Y-mAbs Therapeutics, Inc. CFO Sell 45.0 -4,000 -1.84% ✓ $103.8K
Oct 4, 2021 Oct 5, 2021 Y-mAbs Therapeutics, Inc. CFO Sell 45.0 -4,000 -1.81% ✓ $115.1K
Sep 22, 2021 Sep 23, 2021 Y-mAbs Therapeutics, Inc. CFO Sell 45.0 -4,000 -1.78% ✓ $123.3K
Sep 7, 2021 Sep 8, 2021 Y-mAbs Therapeutics, Inc. CFO Sell 45.0 -4,000 -1.75% ✓ $128.1K
Aug 23, 2021 Aug 24, 2021 Y-mAbs Therapeutics, Inc. CFO Sell 45.0 -4,000 -1.72% ✓ $114.4K
Aug 4, 2021 Aug 5, 2021 Y-mAbs Therapeutics, Inc. CFO Sell 45.0 -4,000 -1.69% ✓ $134.9K
Jul 22, 2021 Jul 26, 2021 Y-mAbs Therapeutics, Inc. CFO Sell 45.0 -4,000 -1.66% ✓ $138K
Jul 6, 2021 Jul 7, 2021 Y-mAbs Therapeutics, Inc. CFO Sell 45.0 -4,000 -1.63% ✓ $136.6K
Jun 22, 2021 Jun 23, 2021 Y-mAbs Therapeutics, Inc. CFO Sell 45.0 -4,000 -1.61% ✓ $144.7K
Jun 4, 2021 Jun 7, 2021 Y-mAbs Therapeutics, Inc. CFO Sell 45.0 -4,000 -1.58% ✓ $133.9K
May 24, 2021 May 26, 2021 Y-mAbs Therapeutics, Inc. CFO Sell 45.0 -4,000 -1.56% ✓ $142.4K
May 13, 2020 May 15, 2020 Y-mAbs Therapeutics, Inc. CFO Sell 17.5 -100,000 -28.01% ✗ $3.7M